Intravenous mesenchymal stem cell transplantation mitigates pulmonary vascular remodeling but poses dose related risks in a pulmonary veno-occlusive disease model.

Stem Cell Res Ther · 2025 · PMC12121274 · PMID 40437633

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Our results showed a trend toward lower levels of NT-proBNP.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

S5 ), the change did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.